Management of Hypoglycemia - Flowchart
Management of Hypoglycemia - Flowchart Hypoglycemia Hypoglycemia
«Flowchart»

Hypoglycemia

Hypoglycemia

Hypoglycemia

Mild to moderate neurological/neuroglycopenic symptoms

Mild to moderate neurological/neuroglycopenic symptoms

Mild to moderate neurological/neuroglycopenic symptoms

Severe neurological/neuroglycopenic symptoms

Severe neurological/neuroglycopenic symptoms

Severe neurological/neuroglycopenic symptoms

Patient not awake and alert

Patient not awake and alert

Patient not awake and alert

Ensure airway protection

Ensure airway protection

Ensure airway protection

Intravenous dextrose initial dose 25 g 50% dextrose

May need maintenance infusion depending on cause, severity and refractoriness of hypoglycemia

Intravenous dextrose initial dose 25 g 50% dextrose

May need maintenance infusion depending on cause, severity and refractoriness of hypoglycemia

Intravenous dextrose initial dose 25 g 50% dextrose

May need maintenance infusion depending on cause, severity and refractoriness of hypoglycemia

Consider glucagon 1 mg IV/SC for recurrent/severe hypoglycemia

Consider octreotide (50 µg SC/IV followed by 50 µg every 6 hours for 3 doses) if sulfonylurea (SU) overdose is suspected

Consider glucagon 1 mg IV/SC for recurrent/severe hypoglycemia

Consider octreotide (50 µg SC/IV followed by 50 µg every 6 hours for 3 doses) if sulfonylurea (SU) overdose is suspected

Consider glucagon 1 mg IV/SC for recurrent/severe hypoglycemia

Consider octreotide (50 µg SC/IV followed by 50 µg every 6 hours for 3 doses) if sulfonylurea (SU) overdose is suspected

Continue close monitoring for recognition and treatment of recurrent hypoglycemia (suspect in cases with large dose insulin or SU overdose)

Continue close monitoring for recognition and treatment of recurrent hypoglycemia (suspect in cases with large dose insulin or SU overdose)

Continue close monitoring for recognition and treatment of recurrent hypoglycemia (suspect in cases with large dose insulin or SU overdose)

End

End

End

Oral glucose tablet (20 g) dextrose-rich oral supplementation

Oral glucose tablet (20 g) dextrose-rich oral supplementation

Oral glucose tablet (20 g) dextrose-rich oral supplementation

Patient awake and alert?

Patient awake and alert?

Patient awake and alert?

Yes

Yes

Yes

No

No

No

Continue close monitoring for recognition and treatment of recurrent hypoglycemia

Continue close monitoring for recognition and treatment of recurrent hypoglycemia

Continue close monitoring for recognition and treatment of recurrent hypoglycemia

Continue evaluation for cause of hypoglycemia

Continue evaluation for cause of hypoglycemia

Continue evaluation for cause of hypoglycemia